PodcastsRank #23151
Artwork for RealTalk MS

RealTalk MS

Jon Strum
Share:
MedicinePodcastsHealth & FitnessENunited-statesDaily or near-daily
4.7 / 5125 ratings
Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You’ll meet the scientists who are creating tomorrow’s MS treatments today. You’ll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we’ll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.
Top 46.3% by pitch volume (Rank #23151 of 50,000)Data updated Feb 10, 2026

Key Facts

Publishes
Daily or near-daily
Episodes
494
Founded
N/A
Category
Medicine
Number of listeners
Private
Hidden on public pages

Listen to this Podcast

Pitch this podcast
Get the guest pitch kit.
Book a quick demo to unlock the outreach details you actually need before you hit send.
  • Verified contact + outreach fields
  • Exact listener estimates (not just bands)
  • Reply rate + response timing signals
10 minutes. Friendly walkthrough. No pressure.
Book a demo
Public snapshot
Audience: 4K–8K / month
Canonical: https://podpitch.com/podcasts/realtalk-ms
Cadence: Active weekly
Reply rate: Under 2%

Latest Episodes

Back to top

An MS Specialist's Response to the FDA with Dr. William Conte

Mon Feb 02 2026

Listen

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investigational disease-modifying therapies to undergo FDA review.    A Complete Response Letter is an official letter from the FDA to a drug manufacturer stating that the agency can't approve a new medicine in its current form. It's not an outright "no" that kills a project; it's more like a "not yet." However, this Complete Response Letter raised some issues which, at first glance, don't appear to be easily fixable. Sanofi has pointed out that the issues raised in the Complete Response Letter were markedly different from the guidance they received from the FDA over the course of this approval process. Sanofi has also indicated that it would work with the FDA to find a path forward for Tolebrutinib. Dr. William Conte, an MS Specialist and a principal investigator in the Phase 3 clinical trial for Tolebrutinib, has published an article responding to the FDA's Complete Response Letter. This week, Dr. Conte joins me to discuss the FDA's action and his response to that action.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're at the 2026 ACTRIMS Forum  :22 Check out the official ACTRIMS Forum Insider podcast!  :42 The FDA's Complete Response Letter about Tolebrutinib  1:09 Dr. William Conte responds to the FDA's Complete Response Letter  4:09 Share this episode  38:10 Next week's episode  38:30 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/440 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Support Jon at WALK MS https://realtalkms.com/walkms Find out about ABLEnow Accounts https://ablenow.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 440 Guests: Dr. William Conte Privacy Policy

More

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investigational disease-modifying therapies to undergo FDA review.    A Complete Response Letter is an official letter from the FDA to a drug manufacturer stating that the agency can't approve a new medicine in its current form. It's not an outright "no" that kills a project; it's more like a "not yet." However, this Complete Response Letter raised some issues which, at first glance, don't appear to be easily fixable. Sanofi has pointed out that the issues raised in the Complete Response Letter were markedly different from the guidance they received from the FDA over the course of this approval process. Sanofi has also indicated that it would work with the FDA to find a path forward for Tolebrutinib. Dr. William Conte, an MS Specialist and a principal investigator in the Phase 3 clinical trial for Tolebrutinib, has published an article responding to the FDA's Complete Response Letter. This week, Dr. Conte joins me to discuss the FDA's action and his response to that action.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're at the 2026 ACTRIMS Forum  :22 Check out the official ACTRIMS Forum Insider podcast!  :42 The FDA's Complete Response Letter about Tolebrutinib  1:09 Dr. William Conte responds to the FDA's Complete Response Letter  4:09 Share this episode  38:10 Next week's episode  38:30 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/440 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Support Jon at WALK MS https://realtalkms.com/walkms Find out about ABLEnow Accounts https://ablenow.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 440 Guests: Dr. William Conte Privacy Policy

Key Metrics

Back to top
Pitches sent
14
From PodPitch users
Rank
#23151
Top 46.3% by pitch volume (Rank #23151 of 50,000)
Average rating
4.7
From 125 ratings
Reviews
29
Written reviews (when available)
Publish cadence
Daily or near-daily
Active weekly
Episode count
494
Data updated
Feb 10, 2026
Social followers
6.4K

Public Snapshot

Back to top
Country
United States
Language
English
Language (ISO)
Release cadence
Daily or near-daily
Latest episode date
Mon Feb 02 2026

Audience & Outreach (Public)

Back to top
Audience range
4K–8K / month
Public band
Reply rate band
Under 2%
Public band
Response time band
3–6 days
Public band
Replies received
6–20
Public band

Public ranges are rounded for privacy. Unlock the full report for exact values.

Presence & Signals

Back to top
Social followers
6.4K
Contact available
Yes
Masked on public pages
Sponsors detected
Yes
Guest format
Yes

Social links

No public profiles listed.

Demo to Unlock Full Outreach Intelligence

We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.

Audience & Growth
Demo to unlock
Monthly listeners49,360
Reply rate18.2%
Avg response4.1 days
See audience size and growth. Demo to unlock.
Contact preview
j***@hidden
Get verified host contact details. Demo to unlock.
Sponsor signals
Demo to unlock
Sponsor mentionsLikely
Ad-read historyAvailable
View sponsorship signals and ad read history. Demo to unlock.
Book a demo

How To Pitch RealTalk MS

Back to top

Want to get booked on podcasts like this?

Become the guest your future customers already trust.

PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.

  • Identify shows that match your audience and offer.
  • Write pitches in your voice (nothing sends without you).
  • Move from “maybe later” to booked interviews faster.
  • Unlock deeper outreach intelligence with a quick demo.

This show is Rank #23151 by pitch volume, with 14 pitches sent by PodPitch users.

Book a demoBrowse more shows10 minutes. Friendly walkthrough. No pressure.
4.7 / 5125 ratings
Ratings125
Written reviews29

We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.

Frequently Asked Questions About RealTalk MS

Back to top

What is RealTalk MS about?

Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You’ll meet the scientists who are creating tomorrow’s MS treatments today. You’ll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we’ll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.

How often does RealTalk MS publish new episodes?

Daily or near-daily

How many listeners does RealTalk MS get?

PodPitch shows a public audience band (like "4K–8K / month"). Book a demo to unlock exact audience estimates and how we calculate them.

How can I pitch RealTalk MS?

Use PodPitch to access verified outreach details and pitch recommendations for RealTalk MS. Start at https://podpitch.com/try/1.

Which podcasts are similar to RealTalk MS?

This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.

How do I contact RealTalk MS?

Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.

Quick favor for your future self: want podcast bookings without the extra mental load? PodPitch helps you find shows, draft personalized pitches, and hit send faster.